| Jacob Thaysen |
Jacob Thaysen is the founder of Cantion A. He is currently the Chief Executive Officer & Director at Illumina, Inc. and also serves as a Director at Lasergen, Inc. Previously, he was the SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc. from 2018 to 2023. He also held positions as a Director at Gen9, Inc., Vice President-Research & Development at Cytologix Corp., and Vice President-System Development, R&D at Dako Denmark ApS. Thaysen received his graduate and doctorate degrees from the Technical University of Denmark. |
| Jakob Wedel |
Jakob Wedel currently works at Illumina, Inc., as Chief Strategy & Corporate Development Officer from 2024. |
| Phillip G. Febbo |
Phillip G. Febbo currently works at American College of Medical Genetics & Genomics, as Director from 2018, Acmg Foundation For Genetic & Genomic Medicine, as Director, Veracyte, Inc., as Chief Scientific & Medical Officer from 2023, and American Society for Clinical Investigation, as Member from 2009. Dr. Febbo also formerly worked at Varian Medical Systems, Inc., as Independent Director from 2019 to 2021, Illumina, Inc., as Chief Medical Officer from 2018 to 2023, Genomic Health, Inc., as Chief Medical Officer from 2013 to 2018, Duke University, as Associate Professor, and The University of California, San Francisco, as Professor from 2010 to 2013. Dr. Febbo received his undergraduate degree from Dartmouth College and doctorate degree from The University of California, San Francisco. |
| Bas Verhoef |
Bas Verhoef is currently the Chief Commercial Officer at Illumina, Inc. since 2024. He is also the Manager at Volcano Europe BV since 2015. Mr. Verhoef holds a doctorate degree from Maastricht University and a graduate degree from Technische Universiteit Eindhoven. |
| Kathryne Reeves |
Kathryne Reeves is currently the Chief Marketing Officer at Illumina, Inc. and is also a member of The International Women's Forum. She previously worked as the Senior Vice President-Enterprise Marketing at Cardinal Health, Inc. Reeves completed her undergraduate degree at Stanford University and earned an MBA from Harvard Business School. |
| Aimee Hoyt |
Currently, Aimee Hoyt is Chief People Officer for Illumina, Inc.
In the past Ms. Hoyt occupied the position of Director-Human Resources for Cisco Systems, Inc., Vice President-Human Resources of HP, Inc., Vice President-Human Resources at International Game Technology, Inc. and Chief Human Resources Officer at Rackspace Technology Global, Inc.
She received a graduate degree from Rochester Institute of Technology. |
| Susan H. Tousi |
Susan H. Tousi is on the board of La Jolla Playhouse, Inc. and BICO Group AB and Chief Commercial Officer of Illumina, Inc.
In her past career she held the position of Vice President & GM-Consumer Inkjet Systems at Eastman Kodak Co. and Program Manager-Research & Development at Phogenix Imaging LLC.
She received an MBA from the University of California, Los Angeles and an undergraduate degree from The Pennsylvania State University. |
| Pat Leckman |
Pat Leckman is currently the Chief People Officer at Illumina, Inc. Prior to this, they obtained an undergraduate degree from Stanford University and an MBA from London Business School. |
| Steven Barnard |
Steven Barnard is currently the Chief Technology Officer at Illumina, Inc. He started this position in 2023. Prior to his current role, he obtained an undergraduate degree from Connecticut College and a doctorate degree from Tufts University. |
| Scott Ericksen |
Scott Ericksen is currently working as the Chief Accounting Officer & Vice President at Illumina, Inc. He started this position in 2022. Prior to his current job, he obtained an undergraduate degree from San Diego State University. |
| John Frank |
Currently, John Frank occupies the position of Chief Public Affairs Officer at Illumina, Inc.
Mr. Frank previously was Vice President-United Nations Affairs at Microsoft Corp.
Mr. Frank received a graduate degree from Columbia Law School and an undergraduate degree from Princeton University. |
| Carissa Rollins |
Carissa Rollins is currently serving as the Chairman at YWCA of Minneapolis. She is also an Independent Director at Owens & Minor, Inc., a Director at Grand Canyon Association, and the Chief Information Officer at Illumina, Inc. Ms. Rollins previously worked as the Chief Information Officer at United HealthCare Services, Inc. She holds an undergraduate degree and an MBA from Marquette University. |
| Kevin Pegels |
Kevin Pegels is currently the Chief-Global Operations at Illumina, Inc. He completed his undergraduate degree at Cornell University and his MBA at Harvard Business School. |
| Ankur Dhingra |
Ankur Dhingra is currently the Chief Executive Officer at ProHance and a Member at The Institute of Chartered Accountants of India. He is also the Chief Financial Officer at Illumina, Inc. starting in 2024. Previously, he held the position of Vice President-Investor Relations at Agilent Technologies, Inc. from 2019 to 2021. He was also the Chief Financial & Accounting Officer at CareDx, Inc. from 2021 to 2022, and at Summit Therapeutics, Inc. from 2022 to 2024. |
| Charles E. Dadswell |
Charles E. Dadswell's current job is as the Secretary, Senior Vice President & General Counsel at Illumina, Inc. He started this position in 2023. Mr. Dadswell's former jobs include being the General Counsel at BioDelivery Sciences International, Inc. from 2008 to 2010, Vice President-US Intellectual Property at GlaxoSmithKline, Inc., and VP, General Counsel-North & Latin America at bioMérieux, Inc. from 2011 to 2013. He also worked as a Principal at Glaxo Wellcome, Inc.Mr. Dadswell's education includes an undergraduate degree from Ferris State University (Michigan), a graduate degree from The Thomas M. Cooley Law School, and another graduate degree from George Washington University Law School. |
| Joydeep Goswami |
Joydeep Goswami is an Independent Director at BioLife Solutions, Inc. He is also a Director at TMune Therapeutics, Inc. and OncoNano Medicine, Inc. Currently, he holds the position of CFO, Chief Strategy & Development Officer at Illumina, Inc. and President at Life Technologies Japan Ltd. Previously, he worked as a Director at Q Therapeutic Products, Inc. and Q Therapeutics, Inc. He also served as the VP-Stem Cell & Regenerative Biology at Invitrogen Corp. and as a Principal at McKinsey & Co., Inc. From 2016 to 2019, he was the President-Clinical Next Generation. Sequencing at Thermo Fisher Scientific, Inc. He has also held the position of Vice President at Life Technologies Corp. Dr. Goswami completed his graduate, MBA, and doctorate degrees from the Massachusetts Institute of Technology. He obtained his undergraduate degree from the Indian Institute of Technology Bombay. |
| Stephen P. MacMillan |
Stephen P. MacMillan is currently the Chairman, President & Chief Executive Officer at Hologic, Inc. since 2015. He is also the Non-Executive Chairman at Illumina, Inc. starting in 2023. Additionally, he serves as a Director at the Advanced Medical Technology Association and as a Trustee at Davidson College. In his former positions, Mr. MacMillan was the Chairman, President & Chief Executive Officer at Stryker Corp. from 2010 to 2012. He was also the Chief Executive Officer at Sbiomed LLC from 2012 to 2013 and an Independent Director at Texas Instruments Incorporated from 2011 to 2012. Furthermore, he served as an Independent Director at Boston Scientific Corp. from 2015 to 2021. He has also held positions as a Director at Alere, Inc., Domain Surgical, Inc., Southwest Michigan. First (Venture Capital), and United Way of The Battle Creek & Kalamazoo Region. Prior to these roles, he was the Sector Vice President-Global Specialty Operations at Pharmacia Corp. from 1999 to 2003 and the President of Johnson & Johnson-Merck Consumer Pharmaceuticals Co. from 1989 to 1999. Mr. MacMillan obtained his undergraduate degree from Davidson College. |
| Robert S. Epstein |
Robert S. Epstein founded Epstein Health LLC in 2012, where he is working as Chairman & Chief Executive Officer from 2012. Dr. Epstein also currently works at Veracyte, Inc., as Chairman, Illumina, Inc., as Independent Director from 2012, Fate Therapeutics, Inc., as Independent Director from 2014, Tasso, Inc., as Director, Intellos Health LLC, as Director, and Biologics & Biosimilars Collective Intelligence Consortium, as Managing Director from 2017. Dr. Epstein also formerly worked at Veracyte SD, Inc., as Chairman from 2019 to 2021, Proteus Digital Health, Inc., as Director from 2013 to 2020, AVEO Pharmaceuticals, Inc., as Independent Director in 2014, Drug Information Association, as Director, On-Q-ity, Inc., as Director from 2010 to 2014, International Society for Quality of Life Research, as Director, Mindstrong, Inc., as Director, Medco Health Solutions, Inc., as Chief Research & Development Officer from 2010 to 2012, Medco Research Institute LLC, as President from 2010 to 2012, Health Outcomes Research Europe SL, as President, and International Society for Pharmacoeconomics & Outcomes Rsch, as President from 1998 to 1999. Dr. Epstein received his graduate degree from the University of Maryland and undergraduate degree and doctorate degree from the University of Michigan. |
| Scott B. Ullem |
Scott B. Ullem is currently a Director at Berry Global, Inc., an Independent Director at Illumina, Inc., and a Director at Egnite, Inc. He was previously the Chief Financial Officer & Vice President at Edwards Lifesciences Corp. and the Chief Financial Officer at Edwards Lifesciences Foundation. Ullem has also held former positions as a Managing Director at Bank of America Corp., an Independent Director at Berry Global Group, Inc., a Managing Director at Banc of America Securities LLC, a Director at The Aspen Institute, Inc., the Chief Financial Officer & Vice President at Bemis Co., Inc., and the Chief Financial Officer & Vice President at CAS Medical Systems, Inc. He also worked as an MD-Investment Banking Services Group at Goldman Sachs & Co. LLC. Ullem received his undergraduate degree from DePauw University and his MBA from Harvard Business School. |
| Caroline D. Dorsa |
Caroline D. Dorsa founded Institute For Advanced Clinical Trials For Children in 2016, where she is working as Director Emeritus from 2016. Ms. Dorsa also currently works at Biogen, Inc., as Chairman from 2023, Illumina, Inc., as Independent Director from 2017, Duke Energy Corp., as Independent Director from 2021, and various other companies. Ms. Dorsa also formerly worked at PSEG Power LLC, as Chief Financial Officer, Director & Executive VP from 2014 to 2015, Biogen Idec New Ventures, Inc., as Director, The Newark Museum of Art, as Director, and various other companies. Ms. Dorsa received her undergraduate degree from Colgate University and Masters Business Admin degree from Columbia Business School. |
| Philip W. Schiller |
Philip W. Schiller is an Independent Director at Illumina, Inc. and a Trustee at Bowdoin College. He was previously the Director-Product Marketing at FirePower Systems, Inc., Senior Vice President-Worldwide Marketing at Apple, Inc., Vice President-Product Marketing at Macromedia, Inc., and a Trustee at Boston College. He also worked as a Manager-Information Technology at Nolan, Norton & Co. BV. Schiller received his undergraduate degree from Boston College in 1982. |
| Gary S. Guthart |
Gary S. Guthart is currently the Chief Executive Officer & Director at Intuitive Surgical, Inc. He is also an Independent Director at Illumina, Inc. and a Director at Silicon Valley Leadership Group. Previously, he served as an Independent Director at Affymetrix, Inc. from 2009 to 2016. He also worked as a Member-Human Factors Research Lab at the National Aeronautics & Space Administration and as a Vice President at Tidal Software, Inc. Dr. Guthart holds a graduate and doctorate degree from the California Institute of Technology and an undergraduate degree from the University of California, Berkeley. |
| Scott Gottlieb |
Scott Gottlieb is currently an Independent Director at Pfizer Inc., Illumina, Inc., and Tempus Labs, Inc. He is also a Director at The Mount Sinai Medical Center, Inc., Aetion, Inc., and National Resilience, Inc. Additionally, he serves as a Special Partner at NEA Management Co. LLC and is a Member of the National Academy of Medicine (United States). In the past, Dr. Gottlieb held positions as an Independent Director at CombiMatrix Corp., Managing Director at T.R. Winston & Co., Inc., and Independent Member of the Board of Directors at Bravo Health, Inc. He also served as a Member of the Board of Directors at MedAvante, Inc., Molecular Insight Pharmaceuticals, Inc., American Pathology Partners, Inc., Gradalis, Inc., Tolero Pharmaceuticals, Inc., and Daiichi Sankyo, Inc. Furthermore, he was a Director at Aseko, Inc. and Targeted Medical Pharma, Inc. Dr. Gottlieb worked as an Analyst at Alex. Brown & Sons, Inc. and as a Senior Adviser to the Administrator at the Centers for Medicare & Medicaid Services (US). He held the position of Deputy Commissioner-Medical & Scientific Affairs at the US Food & Drug Administration from 2005 to 2007 and served as the Commissioner from 2017 to 2019. Dr. Gottlieb completed his undergraduate studies at Wesleyan University and earned a doctorate degree from the Icahn School of Medicine at Mount Sinai. |
| Susan E. Siegel |
Susan E. Siegel is the founder of Stanford Health Care. She currently holds the position of Chairman & Board of Director at The Engine Accelerator, Inc. and Co-Chairman at Stanford Medicine. Additionally, she serves as an Independent Director at Illumina, Inc., Align Technology, Inc., the University of California, Berkeley, The Tech Interactive, RAND Health, Nevro Corp., National Center for Advancing Translational Sciences, Kaiser Family Foundation, Center for Strategic & International Studies, Inc., The National Academies of Science, Women Corporate Directors, and the University of California. She is also a Council Member-Biotechnology Research at the Center for Strategic & International Studies, Inc. and a Member-Presidents Council at The National Academies of Science. In her former positions, Ms. Siegel served as the Chief Innovation Officer & CEO-Business Innovations at GE Aerospace. She was also the President & Director at Affymetrix, Inc., an Independent Director at Pacific Biosciences of California, Inc., and a Director at Crescendo Bioscience LLC, Cellective Dx Corp., RainDance Technologies, Inc., Medtronic Monitoring, Inc., Analyte Health, Inc., DVS Sciences, Inc., The Brigham & Women's Hospital, Inc., and the University of California, Berkeley. She held the position of Director-Baker Bioenginuity Hub at the University of California, Berkeley. Additionally, she served as a Director at National Venture Capital Association, Life Technologies Clinical Services Lab, Inc., On-Q-ity, Inc., Silicon Valley Technical Institute, Bio-Rad Laboratories, Inc., EIDP, Inc., and Global Life Sciences Solutions USA LLC. She was the Chief Innovation Officer at GE Ventures LLC and a Partner at MDV Management Co. LLC. She also served as the President of Hoefer Pharmacia Biotech, Inc.
Ms. Siegel completed her undergraduate studies at the University of Puerto Rico and her graduate studies at Boston University School of Medicine. |
| Andrew Joseph Teno |
Andrew Joseph Teno is currently the President, Chief Executive Officer & Director at Icahn Enterprises LP since 2024. He is also an Independent Director at Illumina, Inc. since 2023, an Independent Director at Southwest Gas Holdings, Inc. since 2022, and a Portfolio Manager at Icahn Capital LP since 2020. In his former positions, Mr. Teno served as an Independent Director at Cheniere Energy, Inc. from 2021 to 2022, an Independent Director at FirstEnergy Corp. from 2021 to 2023, an Independent Director at Crown Holdings, Inc. from 2022 to 2023, an Independent Director at Eco-Stim Energy Solutions, Inc. from 2017 to 2018, an Independent Director at Herc Holdings, Inc. from 2021 to 2023, a Director at Fir Tree Partners, Inc. from 2011 to 2020, a Director at Herc Rentals, Inc. from 2021 to 2023, and an Associate at Fir Tree Capital Management LP from 2011 to 2020. He also worked as an Analyst at Gleacher Partners LLC and an Associate at Crestview Advisors LLC from 2009 to 2011. Mr. Teno obtained his undergraduate degree from The Wharton School of the University of Pennsylvania in 2007. |
| Frances Hamilton Arnold |
Frances Hamilton Arnold is the founder of Gevo, Inc. (2005), Provivi, Inc. (2014), and Aralez Bio (2019). She is currently the Co-Chairman of the President's Council of Advisors on Science & Technology, Vice Chairman of Gordon Research Conferences, Independent Director of Illumina, Inc. (since 2016), Director & Professor at California Institute of Technology (since 1986), Independent Director of Alphabet, Inc. (since 2019), Director of Donna & Benjamin M Rosen Bioengineering Center, Director of National Resilience, Inc. (since 2020), Director of Generate Biomedicines, Inc. (since 2019), Director of Altos Labs, Inc., Board of Advisor at Angeleno Group LLC, and Venture Partner at Catalio Capital Management LP. She received her undergraduate degree from Princeton University and her doctorate from the University of California, Berkeley. |
